Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

Axel Åkerblom, Robert M. Clare, Yuliya Lokhnygina, Lars Wallentin, Claes Held, Frans Van De Werf, David J. Moliterno, Uptal D. Patel, Sergio Leonardi, Paul W. Armstrong, Robert A. Harrington, Harvey D. White, Philip E. Aylward, Kenneth W. Mahaffey, Pierluigi Tricoci

Research output: Contribution to journalArticlepeer-review

Abstract

Background Albuminuria is associated with cardiovascular (CV) outcomes. We evaluated albuminuria, alone and in combination with estimated glomerular filtration rate (EGFR), as a predictor of mortality and CV morbidity in 12,944 patients with non-ST-segment elevation acute coronary syndromes. Methods Baseline serum creatinine and urinary dipsticks were obtained, with albuminuria stratified into no/trace albuminuria, microalbuminuria (≥30 but

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalAmerican Heart Journal
Volume178
DOIs
Publication statusPublished - Aug 1 2016

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial'. Together they form a unique fingerprint.

Cite this